Podcasts about American Heart Association

Many people worry about memory loss and cognitive decline as they age. In this episode of Health Matters, host Courtney Allison speaks with Dr. Matthew Fink, neurologist-in-chief at NewYork-Presbyterian and Weill Cornell Medicine, about how lifestyle choices—especially diet—can help protect the brain. Dr. Fink explains the MIND diet, a combination of the Mediterranean and DASH diets, which emphasizes whole foods like leafy greens, berries, fish, nuts, and olive oil while limiting salt, sugar, and ultra-processed foods. He breaks down how key nutrients such as B vitamins and antioxidants support brain metabolism, reduce inflammation, and may slow the aging process. The conversation also highlights the brain's high energy demands and why proper nutrition is essential for cognitive function. Dr. Fink shares research showing that healthy lifestyle interventions can significantly lower the risk of dementia and discusses the broader benefits of the MIND diet for heart health and stroke prevention. Finally, Dr. Fink outlines additional habits that support brain health, including regular physical activity, quality sleep, and social connection, emphasizing that even small, gradual changes can lead to meaningful long-term benefits.   Chapters 00:00 – Why Brain Health Is in Your Control How lifestyle choices can reduce dementia risk and why prevention starts early 03:00 – What Is the MIND Diet? Key components of the Mediterranean and DASH diets and how they support the brain 06:00 – Brain-Boosting Nutrients and Foods to Avoid The role of B vitamins, antioxidants, and which foods increase risk 10:30 – Beyond Diet: Exercise, Sleep, and Daily Habits How movement, rest, and social connection contribute to cognitive health     Key Topics Covered MIND diet overview Mediterranean diet and DASH diet Brain metabolism and energy use B vitamins and brain health Antioxidants and inflammation Foods that support cognitive function Foods to limit (salt, sugar, processed foods) Dementia and Alzheimer's prevention Stroke and heart disease connection Exercise and brain function Sleep and cognitive health Lifestyle changes for healthy aging   Takeaway Message You have more control over your brain health than you might think. By focusing on whole, nutrient-rich foods, limiting processed options, staying active, and getting enough sleep, you can significantly reduce your risk of cognitive decline and support a healthier brain as you age.   Doctor Bios Matthew E. Fink, MDis currently the Louis and Gertrude Feil Professor and chair of the Department of Neurology at Weill Cornell Medicine, and neurologist-in-chief at NewYork Presbyterian/Weill Cornell Medical Center.  In addition, he is chief of the Division of Stroke and Critical Care Neurology at NewYork-Presbyterian/Weill Cornell Medical Center, and vice chair of the medical board. Dr. Fink attended college at the University of Pennsylvania, medical school at the University of Pittsburgh, and served as resident and chief resident in internal medicine at the Boston City Hospital. He came to New York and trained in neurology at the Neurological Institute of NewYork-Presbyterian/Columbia University Irving Medical Center, and served as chief resident under Dr. Lewis P. Rowland. Subsequently, he joined the faculty of Columbia University and became the founding director of the Neurology-Neurosurgery Intensive Care Unit at NewYork-Presbyterian and was appointed associate professor of clinical neurology and neurosurgery while at Columbia. Dr. Fink was a founding member and chair of the critical care section of the American Academy of Neurology, and the research section for neurocritical care of the World Federation of Neurology. He is board-certified in internal medicine, neurology, critical care medicine, vascular neurology, and neurocritical care.  He has been elected as a Fellow of the American Neurological Association, the American Academy of Neurology, and the Stroke Council of the American Heart Association. Throughout his career, Dr. Fink has been involved in the education and training of students, residents and fellows in the field of stroke and critical care neurology, as well as an active participant in clinical research within this field. He is a leader in this new specialty, has lectured widely, and has published many research and clinical articles in the field of stroke and critical care. In addition, he currently serves as editor of the monthly publication, NEUROLOGY ALERT, and is a past-president of the New York State Neurological Society.

In this episode, preventive cardiologist Dr. Ann Marie Navar, a member of the committee that helped shape the American Heart Association's new recommendations for earlier cholesterol management, explains why many experts believe cardiovascular prevention should begin decades before most people ever experience symptoms. Dr. Navar explains why lowering LDL cholesterol earlier in life can have lasting benefits decades later, how ApoB and lipoprotein(a) are reshaping the way experts think about heart disease risk, and why some of the most popular fears surrounding statins aren't supported by the evidence. The conversation also explores the growing divide between evidence-based medicine and the wellness industry and the challenges of separating compelling biological theories from treatments that have actually been proven to improve health outcomes. She's a wealth of knowledge and a wonderful guest. Hope you enjoy.

Mark Ezzell, Director of the North Carolina Governor's Highway Safety Program, was in his early 20s when his father, Sen. Jim Ezzell, died on Capital Boulevard in Raleigh on the eve of session starting in 1991.   That loss not only changed Mark's life forever, it also created an opening in the North Carolina Senate for a young House member named Roy Cooper. But this story is about more than politics, it's also about perseverance and grace.   Senator Ezzell, who lived with cerebral palsy, and his wife made the intentional decision to adopt a child with a disability. At age eight, Mark was adopted from foster care and welcomed into a family that saw his potential, not his limitations. Born with spina bifida, Mark has spent his life navigating challenges from a wheelchair while building a successful career in public service, including his work today of preventing highway fatalities.   Plus, Skye and Brian unpack another busy week: state budget negotiations continue, a moratorium on certain property tax increases heads to Governor Stein's desk, political news, a state senator has his eyes on a mayor's office, and graduation ceremonies are getting out of hand.   The Do Politics Better podcast is sponsored by New Frame, the NC Travel Industry Association, the American Heart Association, the NC Pork Council, the NC Realtors, Heal the System NC, and the NC Healthcare Association.

#thismorning | #Move More for Your #Health, Not Just for the #Scale | Damon L. Swift, Ph.D, American Heart Association & University of Virginia | #Tunein: broadcastretirementnetwork.com #Aging, #Finance, #Lifestyle, #Privacy, #Retirement, #wellness

Click to Text Thoughts on Today's EpisodeWhen a friend described drooping eyes, slurred words, and fuzzy thinking at brunch — and then brushed it off as anxiety — I knew something wasn't right. That conversation sparked this important Common Sense episode on recognizing the warning signs of stroke, TIA, and heart attacks, and why acting fast can make all the difference. I hope this episode gives you a little more confidence and a little less hesitation if you ever need it. Share it with someone you love. It might matter more than you know.In This Episode:Why women are more likely to dismiss their symptoms — and the cost of waitingThe FAST acronym for stroke and TIA: F — Face droopingA — Arm weaknessS — Speech difficultyT — Time to call 911What a TIA (transient ischemic attack) is and why feeling better doesn't mean you're in the clearAdditional stroke warning signs beyond FASTHow heart attacks present differently in women — including jaw pain, back pain, nausea, fatigue, and shortness of breath with no chest pain at allWhy you should call 911 instead of driving yourselfA personal reflection on loss and the what-ifs we carryEpisodes Discussed:500th Episode: ​5 Uncomfortable Lessons from 500 Episodes​For more information on heart attacks and stroke visit:American Heart Association — heart.org — covers both heart attack and stroke, very thorough, well-organized for general audiencesAmerican Stroke Association — stroke.org — technically a division of AHA but has its own dedicated stroke content including FAST informationMy latest recommended ways to nourish and move your body, mind and spirit: Nourished Notes Bi-Weekly Newsletter30+ Non-Gym Ways to Improve Your Health (free download)Connect with Amy: GracedHealth.com Instagram: @GracedHealthYouTube: @AmyConnell

Host Jeremy C. Park interviews Missy Acosta, Senior Vice President, Brand Experience with Delta Dental of Tennessee, who highlights Tennessee's largest dental benefits carrier and their differentiation as a not-for-profit 501(c)4 with a mission of "Ensuring Healthy Smiles" and a focus on philanthropy and community investment. Missy talks about Delta Dental of Tennessee's charitable arm, The Smile180 Foundation, which was founded in 2014 with three philanthropic pillars: to increase access to dental care for underserved communities, support children's hospitals, and fund oral health education across Tennessee and beyond. Missy shares a number of examples how their support of charitable dental clinics, including Church Health and Christ Community Health Services in Memphis and Neighborhood Health and Interfaith Dental in Nashville are increasing access to dental care for underserved communities. She discusses why oral health is a top priority for children's hospitals, including St. Jude Children's Research Hospital and Monroe Carell Jr. Children's Hospital at Vanderbilt, and explains why their support of oral health education covers everything from kids television programming to promote healthy habits to supporting colleges of dentistry in Tennessee to help equip the next generation of dentists and oral hygienists to be successful and to help address dental deserts across the state. Missy talks about how these efforts tie in with the Healthy Smiles Initiative, along with some of their other philanthropic efforts, including providing mouth guards to youth playing sports through various organizations and affiliations. Missy then highlights their fifth annual Kids Dental Day, scheduled for Friday, July 10 at First Horizon Park, home of the Nashville Sounds. More than 500 youth from various nonprofits in Middle Tennessee will be attending the fun, festival-like event where they will receive free dental screenings, cleanings, new socks and shoes through a partnership with Soles4Souls, new books through Book 'Em, snacks, and more. Over 100 volunteers will be coming out to support the kids and a number of organizations will be providing interactive games and experiences, like PBS Kids, American Red Cross, Adventure Science Center, American Heart Association, Schenk Photography, and the Colgate Bright Smiles Bright Futures Program. The dental organizations participating include Neighborhood Health, Meharry School of Dentistry, South College, LINKS INC., and Hope Smiles. Partners for the event include Nashville Sounds, cityCURRENT, Signature Transportation, United Way, Kroger, OneGen, Henry Schein, and Dunkin. Missy talks about why this annual event is so important in the community and how this can serve as inspiration for other companies to give back and get more involved in making a difference. Missy closes by inviting youth-serving organizations and volunteers who wish to serve to connect with KidsDentalDay.com to learn more and to plan ahead for next year. Visit www.KidsDentalDay.com to learn more about Kids Dental Day and visit https://deltadentaltn.com to learn more about Delta Dental of Tennessee.

In part two of this series, Dr. Andy Southerland and Dr. Dan Ackerman discuss a few rapid‑fire concepts from the 2026 guidelines, focusing on what is new and how emerging data may shape patient care.  Show transcript:  Dr. Andy Southerland: Hello, everyone. This is Andy Southerland from the University of Virginia. And for today's Neurology Minute, I'm speaking with my friend and colleague, Dan Ackerman, Chief of Neurology and Director of Stroke at St. Luke's University Health System. We've been speaking in the main neurology podcast on tips for updated clinical practice related to the 2026 American Heart Association guidelines for the early management of patients with acute ischemic stroke. I'm going to hit Dan with a few rapid fire concepts that were touched on the guidelines that I think are new or provide some new insights, new based on the data and to how we treat patients. So Dan, you ready for it? Rapid fire, acute stroke treatment decision making? Dr. Dan Ackerman: Absolutely. Hit me. Dr. Andy Southerland: All right, Dan. I'm a resident going to my first stroke alert on July one this year and I've got a patient coming in, they're having disabling stroke symptoms and they're, in every other way, eligible to receive thrombolysis, but they have a history of paroxysmal atrial fibrillation. They are on apixaban and they took a dose of that apixaban. They forgot to take one yesterday, but they took one the day before, had the evening before. And so 36 hours ago, they took a dose of their apixaban. So based on previous dogma, I think prior guidelines might've said if it's within that 48 hour window, that's a relative contraindication of thrombolysis. What, say, you based on the new guidelines and then how do they inform us about making that decision? Dr. Dan Ackerman: I would actually say the new guidelines are a little bit more aligned with what you just said. You mentioned it as a relative contraindication to thrombolysis. I think before these guidelines came out, a lot of people would've said, "No, that is a strict contraindication to thrombolysis." And a lot of folks would run a stroke code or a stroke lid a little slower knowing that, hey, this person is on, whether it's apixaban, rivaroxaban, edoxaban, dabigatran, et cetera, any of these direct oral anticoagulants and say, "Well, no, we know that person's not a candidate for thrombolytics." Well, no, the newer guidelines would suggest that that is a relative contraindication, not a strict contraindication. And when we look back at studies on this, it has not been suggested that there is a big contribution in terms of exactly how long ago that last dose was. Was it two hours ago, 12 hours ago, 20 hours ago? And there has not been shown to be a clear benefit of testing for factor Xa activity levels, bleeding time and the like. So the guidelines do suggest that, hey, we need more data on this. It's not to, say, that this is 100% perfectly fine. Remember, that's a relative contraindication, so it's still a risk benefit discussion, but studies have not shown an increased risk for hemorrhagic complications in patients who have had recent DOAC exposure who receive IV thrombolysis otherwise according to the guidelines. So I would tend to offer it in that situation and make sure that we document what drugs someone's on, how long ago was their last dose, all of this kind of information in addition to what we might normally otherwise get down. Dr. Andy Southerland: Does that change, Dan, if they took the DOAC in the last 24 hours or even 12 hours? They took it last night, and they're presenting in the morning with their stroke-like symptoms? Dr. Dan Ackerman: The guideline just suggests less than 48 hours, and the data, to my knowledge, doesn't really delineate, at this point, any particular timeframe where we would say, no, there's a cutoff there at two hours or eight hours or 12 hours. So at this point, I would not use that as a way to decide not to offer thrombolysis based on that timeframe. Dr. Andy Southerland: Fair enough. I think that's very reasonable. And I think, again, it's always a good conversation to have either with your attending, if you're that resident on July 1, but particularly with the patient and their family on the risk-benefit of what we know based on the data. Well, that's all the time we have for this Neurology Minute. We hope this discussion will continue to help everyone out there in the hyperacute management of patients with acute ischemic stroke, making those difficult treatment decisions. Good luck.  

In part one of this series, Dr. Andy Southerland and Dr. Dan Ackerman discuss what stands out in the latest thrombolysis guidelines, how these decisions are applied in stroke center practice, and how to educate residents and fellows on incorporating new evidence into treatment choices. Show transcript: Dr. Andy Southerland: Hi. This is Andy Southerland from the University of Virginia, and for today's Neurology Minute, I'm speaking with my friend and colleague, Dan Ackerman, Chief of Neurology and Director of Stroke at St. Luke's University Health System. I've been speaking with Dan on the main neurology podcast regarding updates to acute stroke treatment related to the 2026 American Heart Association guidelines that came out in late January of this year on the early management of patients with acute ischemic stroke. For our episode today, we might focus our discussion around thrombolytic therapy thrombolysis, which is at the core of what we do as acute stroke neurologists when it comes to treatment decision-making. So maybe as a first prompt, Dan, when you look at these guidelines, what stands out to you as you're thinking about how you practice, how you all are practicing at your stroke center, and then specifically how we educate our residents, our fellows on what they need to know, particularly the newness of it when it comes to making thrombolysis treatment decisions? Dr. Dan Ackerman: With all the discussions we've had in the past, there have been a lot of specifics about certain studies and how they might affect practice, but this guideline really opened up a lot and gave us an opportunity to do things in a way that makes really good clinical sense and really brings a lot of practices that have now become common at some centers into the fore so that we can get that information out to everyone and make sure everyone has that same really high level of stroke care everywhere they go. I think the first thing that stands out to me is what did not change. And want to reinforce that, particularly for people who are just getting into this, stroke alert is a screening tool, not a severity score. It's not like an MI alert where you do an EKG and you see the tombstone wave and you say, "Oh, there's an MI and we're taking them to treatment." This is a screening tool, so it is meant to be highly sensitive at the cost of being specific. At our shop for a long time now, we have initiated stroke alert for anyone who presents either within 24 hours of acute onset of neurologic symptoms or has an unknown onset of acute neurologic symptoms and they are still symptomatic to some degree at the time of their presentation, and that's it. We don't make any other statements about how severe something is or what kinds of symptoms someone necessarily has to have. We purposely keep it as broad as possible, again, because we're trying to screen. And the other thing that has not changed, time is still brain. So with all of these different nuances on how we can treat patients and who might be candidates for intervention, it is still a matter of understanding these guidelines, applying our best evidence, but doing it as quickly as possible to make sure that we are rescuing as much of that ischemic penumbra as we possibly can. Now, aside from that, in terms of what stands out that is different, I think one of the early things for me are the recommendations for extended time window for IV thrombolysis. So when you look at the original studies, we understand that when you get out beyond four and a half hours, if you just take all-comers, the risk is going to start to outweigh the benefit. But that doesn't mean there's zero benefit or that no one would receive benefit, but it's a question of, well, how do we cherry-pick those patients who may still receive benefit? And there are a few real specifics in the guideline that help us figure that out. One is for patients who have an unknown time of onset, but they're within four and a half hours of symptom discovery. And for those patients, they would suggest that doing a stat MRI and comparing a DWI lesion with the corresponding area flare to determine if you see DWI hyper-intensity and the flare image is nice and normal, that would suggest that stroke is young enough that it may still be appropriate to treat that patient. But we would also say for folks who have salvageable ischemic penumbra, so again, brain at risk that is not core yet, who either awoke with stroke symptoms within nine hours from the midpoint of sleep or, and this is the kicker, are within four and a half to nine hours from last known well. So in other words, they may have been symptomatic already for more than four and a half hours. If those patients have an appropriate ischemic penumbra, it may be reasonable to treat them with IV thrombolysis to improve functional outcomes. Dr. Andy Southerland: Well, that's all for this Neurology Minute. We hope this vibrant conversation will help all those who are out looking to make the best treatment decisions for their patients, both based on established evidence and most recent evidence in our new guidelines.  

Doctor Mau Informa ®️ #drmauinforma Cuando discutimos la diabetes tipo 2 y la prediabetes, nuestro enfoque se centra casi exclusivamente en restringir los carbohidratos y perder peso. Sin embargo, los datos de los ensayos clínicos más recientes revelan un punto ciego enorme en nuestros paradigmas de atención: el músculo esquelético es nuestro órgano de eliminación de glucosa más grande, e ignorarlo acelera el envejecimiento metabólico. En este episodio, desglosamos las pautas clínicas y los datos de ensayos más recientes que demuestran por qué el entrenamiento de hipertrofia mecánica funciona como una poderosa intervención no farmacológica para el control del azúcar en sangre, incluso para personas con un peso normal. En este episodio aprenderás: → Por qué la diabetes tipo 2 actúa como un factor de riesgo independiente para la sarcopenia acelerada y el declive de la función muscular. → Los datos moleculares que demuestran que el entrenamiento de resistencia mejora la HbA1c en aproximadamente un 0.57% y la glucosa en ayunas en ~7 mg/dL. → Por qué el entrenamiento de hipertrofia es significativamente superior al entrenamiento de resistencia a la fatiga para la inflamación sistémica y la retención de masa magra. → Los sorprendentes resultados del ensayo Kobayashi: por qué el entrenamiento de fuerza venció al cardio en la diabetes tipo 2 de peso normal. → Los parámetros de programación exactos de la Asociación Americana de Diabetes y el ACSM necesarios para optimizar la eliminación metabólica en la práctica.

Former NC Lieutenant Governor Dan Forest sits down for a candid conversation about the twists and turns that have shaped his life, career, and outlook on the future.   The Republican reflects on growing up in a political family, how his parents' divorce affected him and influenced his views on faith, family, and perseverance. He also opens up about one of the most difficult chapters of his public life: his 2020 gubernatorial loss, what he learned from the experience, and how it changed his perspective on politics and leadership. Today, Forest has embarked on a new chapter that he says he genuinely loves. As a lobbyist and leader of a coalition focused on blockchain technology and AI, he is helping businesses and policymakers navigate some of the most transformative innovations of our time. He discusses the opportunities and challenges presented by AI, the future of cryptocurrency, and why he believes emerging technologies will reshape government, business, and everyday life. Plus, Skye and Brian break down the latest developments at the General Assembly, including a budget update, several key bills on the move, and a notable veto override. They also take a look at the stories shaping the week across North Carolina before turning their attention to the state's collective obsession: the Carolina Hurricanes.  The Do Politics Better podcast is sponsored by New Frame, the NC Travel Industry Association, the American Heart Association, the NC Pork Council, the NC Realtors, Heal the System NC, and the NC Healthcare Association.

You've probably heard of a sweet tooth, the term for people who love sugary foods and desserts. But you might be less familiar with a salt tooth. In other words a  preference for salty foods, such as crisps, olives, cheese and other salty things.  According to a study presented at the American Heart Association's Scientific Sessions meeting in 2016, there is a genetic basis for your salt cravings. Some people carry a variation of a gene that may give them more of a taste for salt. This gene also affects how people perceive bitterness, which may explain why people with a salt tooth tend to avoid foods such as broccoli and dark leafy greens. What causes a salt tooth, and is it bad for your health ? How can you satisfy your salt tooth without harming your health ? In under 3 minutes, we answer your questions ! To listen to the last episodes, you can click here : ⁠⁠What is brain tapping, the viral technique for improving sleep quality?⁠⁠ ⁠⁠What is the half and half drinking method?⁠⁠ ⁠⁠How can heatwaves impact our mental health?⁠⁠ A podcast written and realised by Amber Minogue. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Casandra MacLeod discusses central retinal artery occlusions, recent trials, and those anticipated in the future.  Show citation:  Préterre C, Gaultier A, Obadia M, et al. Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4·5 h of severe vision loss (THEIA): a multicentre, double-dummy, patient-blinded and assessor-blinded, randomised, controlled, phase 3 trial. Lancet Neurol. 2025;24(11):909-919. doi:10.1016/S1474-4422(25)00308-4  Poli S, Grohmann C, Wenzel DA, et al. Early REperfusion therapy with intravenous alteplase for recovery of VISION in acute central retinal artery occlusion (REVISION): Study protocol of a phase III trial. Int J Stroke. 2024;19(7):823-829. doi:10.1177/17474930241248516  Ryan SJ, Jørstad ØK, Skjelland M, et al. A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion. N Engl J Med. 2026;394(5):442-450. doi:10.1056/NEJMoa2508515 Show transcript:  Dr. Casandra MacLeod Hello, this is Casandra MacLeod, a neurology resident at Cleveland Clinic with today's Neurology Minute. Today we will be discussing central retinal artery occlusions, or CRAOs, and the recent trials that have come out and even those further on the horizon. The 2026 American Heart Association and American Stroke Association guidelines for the early management of patients with acute ischemic stroke were recently published and in them highlight the uncertainty around the treatment of acute CRAOs with intravenous thrombolysis, even when the patient presents within four and a half hours and is otherwise eligible. These guidelines come after two recent trials, which we will further discuss. The thrombolysis in patients with acute central retinal artery occlusion, or the THEIA trial, was published in the November issue of Lancet Neurology. This multicenter trial out of France randomized 70 patients with acute CRAOs presented within four and a half hours of time from last known well to either receive IV alteplase and oral placebo or IV placebo and oral aspirin. While safety measures showed no symptomatic hemorrhage event, although they did have one asymptomatic intracerebral hemorrhage occur, the primary outcomes, which included visual acuity improvement at one month, showed some evidence for a trend of improved acuity in the IV thrombolytic group at 66% compared to 48 in the aspirin group, it did not reach significant. And now more recently, the Tenecteplase in central retinal artery occlusion study, or TenCRAOs, was published in the January 2026 issue of The New England Journal of Medicine. TenCRAOs was a six European country multicenter trial that randomized 78 patients with CRAOs all presenting within four and a half hours of time from last known well to either receive IV Tenecteplase or aspirin, both with placebo-matching as in THEIA. The primary outcomes of TenCRAOs also included visual acuity at one month, but unfortunately this trial also did not show [inaudible 00:02:07]. They showed 20% in the IV TNK group compared to 24% in aspirin. And additionally, there was one fatal intracerebral hemorrhage in the TNK group that should be considered. Overall, the AHA and ASA guidelines state the usefulness of treatment with intravenous thrombolysis is uncertain. And this is based largely on these studies as neither trial showed improved visual recovery. Although both of these trials are underpowered, leading many to believe that the jury is still out on the use of IV thrombolytics in CRAOs. But importantly, stay on the lookout for one last trial. The early reperfusion therapy with intravenous alteplase for recovery of vision and acute central retinal artery occlusion, or the Revision trial, is actively recruiting. Revision is similar in design as THEIA, but with a goal of up to 422 total patients for a goal of a well-powered study to guide decision making. 

Bob Harringson and former FDA commissioner Rob Califf discuss medical misinformation, its impact on public and individual health, and how to fight against it. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington  Is a Long-Simmering Crisis Boiling Over? U.S. Primary Care Today https://doi.org/10.1056/NEJMms2510425 The Global Wellness Economy Hits a Record $6.8 Trillion and Is Forecast to Reach $9.8 Trillion by 2029 https://globalwellnessinstitute.org/press-room/press-releases/the-global-wellness-economy-hits-a-record-6-8-trillion-and-is-forecast-to-reach-9-8-trillion-by-2029/  Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association https://doi.org/10.1161/CIR.0000000000001078  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(04)17018-9/abstract  Here's What We Know https://weillcornell.org/heres-what-we-know  Fifth Circuit sides with ivermectin-prescribing doctors in their quarrel with the FDA https://www.courthousenews.com/fifth-circuit-sides-with-ivermectin-prescribing-doctors-in-their-quarrel-with-the-fda/  SNAP Tracker: People Are Losing Food Assistance as the Republican Megabill Is Implemented https://www.cbpp.org/research/food-assistance/snap-tracker-people-are-losing-food-assistance-as-the-republican-megabill  Chronic Conditions and Food Insecurity in US Children https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2839376  As Unregulated Peptides Flood the Market, Clinicians Encouraged to Counsel Patients https://www.medscape.com/viewarticle/unregulated-peptides-flood-market-clinicians-encouraged-2026a1000e63 Coethia https://coethia.com/  You may also like: Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology https://www.medscape.com/twic  Questions or feedback, please contact news@medscape.net

In this episode, Dr Swapnil Pawar is joined by Dr Jose Chacko to discuss the 2026 American Heart Association and American College of Cardiology guidelines on the management of pulmonary embolism. We cover the new A to E classification, evaluation and diagnostic algorithms, acute management including the role of PERT teams, advanced reperfusion therapies, and the updated recommendations on anticoagulation and follow-up. Welcome back after two years.

Welcome back, everyone. Today we're diving into one of the most hotly debated topics in obstetrics- should we be treating preeclampsia without severe features with antihypertensive medications during expectant management? Now, if you've been following the literature- and our show, you know that the landmark CHAP trial changed the game for chronic hypertension in pregnancy. It showed us that targeting a blood pressure below 140 over 90 reduces serious maternal complications, without harming the baby. That was a big deal. But here's the thing, CHAP studied chronic hypertension. Then there was the CHIP trial- that also found that tight control of gestational hypertension and nonproteinuric chronic hypertension was also beneficial. These did not address preeclampsia without severe features, and yet, the ripple effects of that trial have sparked a global conversation about whether we should be extending those same treatment principles to women with preeclampsia who don't yet have severe features. And this is where it gets really interesting, because the guidelines don't agree. In the United States, ACOG and the Society for Maternal-Fetal Medicine still say: hold off on antihypertensives unless blood pressures hit the severe range at 160/110. But step outside the US, and you'll find the World Health Organization, the International Society for the Study of Hypertension in Pregnancy, FIGO, NICE, and Hypertension Canada all recommending treatment at 140 over 90, regardless of whether the diagnosis is chronic hypertension, gestational hypertension, or preeclampsia. So who's right? And more importantly what does this mean for the patient sitting in front of you right now, at 34 weeks, with a blood pressure of 150 over 95, some proteinuria, but no severe features? Today, we're going to break this down. We'll review the controversy, walk through the divergent guidelines, and most importantly talk about the real, practical implications that favor treating these patients during expectant management. Because when you're watching someone with preeclampsia, waiting for the right time to deliver, there's a strong argument that controlling their blood pressure isn't just reasonable…may be protective. So grab your coffee, settle in, and let's get into it.1. Society for Maternal-Fetal Medicine Statement: Antihypertensive Therapy For mild chronic Hypertension in Pregnancy-The Chronic Hypertension And Pregnancy Trial. American Journal of Obstetrics and Gynecology. 2022. Society for Maternal-Fetal Medicine; Publications Committee. 2. Preeclampsia. The New England Journal of Medicine. 2022. Magee LA, Nicolaides KH, von Dadelszen P.3. Antihypertensive Drug Therapy for Mild to Moderate Hypertension During Pregnancy.The Cochrane Database of Systematic Reviews. 2018. Abalos E, Duley L, Steyn DW, C.4. Prevention and Treatment of Maternal Stroke in Pregnancy and Postpartum: A Scientific Statement From the American Heart Association. Stroke. 2026. Miller EC, Bello NA, Chen PR, et al.5.Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertension. 2022. Garovic VD, Dechend R, Easterling T, et al.

Dr. Arreaza: Hello, everyone, my name is Dr. Hector Arreaza, I am a family physician and an associate program director in the Clinica Sierra Vista – Rio Bravo Family Medicine Residency Program.  Today we're discussing one of the most powerful predictors of health that many people rarely think about: geography. Where someone lives can influence everything from access to physicians and emergency care to chronic disease outcomes and life expectancy. Joining us today is Peyton, who will be taking a deeper look into the matter. Peyton, thank you for being here — can you start by introducing yourself, please? Peyton: Hello, thank you for having me. My name is Peyton, I am a 4th year medical student with Western Atlantic University, and I am from a very small town in South Dakota.  Dr. Arreaza: Peyton, you are on your last few days in your FM rotation, when are you graduation?  Peyton, you prepared this topic and it is great. When people hear the phrase “your ZIP code can determine your health,” what does that actually mean? Peyton: It basically means that where someone lives can significantly influence their health outcomes and even life expectancy. A person's ZIP code can affect access to physicians, hospitals, transportation, emergency services, and preventative care. Arreaza: Talking about prevention. The American Heart Association agrees with you because Zip code is not part of the cardiovascular risk calculator called PREVENT. I invite everyone to take a look at this new calculator. I think a lot of people assume healthcare is equal as long as hospitals or clinics exist nearby, right? Peyton: Yes, patients may still struggle with overcrowded healthcare systems, which can lead to long wait times. In fact, a national physician appointment survey found that average wait times for new patient primary care appointments in major cities can exceed three weeks, with some cities reporting significantly longer delays depending on specialty access and provider availability. Dr. Arreaza: And when patients experience those kinds of delays, they may frequently switch between providers, which becomes much harder to establish consistent long-term care. Peyton: One of the biggest issues many patients face is continuity of care — having consistent follow-up with the same provider over time. Dr. Arreaza: And that continuity really matters in medicine, especially family medicine, it is one of our keywords: continuity of care. Peyton: Exactly. Preventative care and chronic disease management work best when patients have long-term relationships with healthcare providers. But in many underserved communities, patients may wait months for appointments, frequently change providers, or rely on emergency rooms instead of primary care clinics. Dr. Arreaza: And urgent care too. When care becomes fragmented, conditions like hypertension, diabetes, and chronic illnesses can become much harder to manage. Peyton: Exactly. Delayed screenings, missed follow-up appointments, and lack of preventative care often lead to patients presenting later with more advanced disease that could have been treated earlier. Dr. Arreaza: And urban communities may face some of the same challenges, but rural communities are at a different level of barriers to health care. Peyton: Absolutely. Rural communities often experience significant physician shortages. According to the Health Resources and Services Administration, over 100 million Americans live in primary care shortage areas, and nearly 65% of those shortage areas are located in rural regions. Peyton: I think one of the biggest solutions starts with strengthening primary care and investing more heavily in underserved communities, especially rural areas. Dr. Arreaza: And that includes increasing the number of physicians going into family medicine and primary care specialties.  Peyton: Here is an interesting fact: According to the Graham Center, Northeastern states receive high graduate medical education (GME) funding but produce relatively fewer primary care physicians. Northwestern states receive low GME funding but perform relatively better, producing slightly above the U.S. average (70.8 vs 69.8 primary care physicians per 100,000 people). However, even this remains far below Canada's average of 119 primary care physicians per 100,000 people.  Right now, the United States is facing a growing physician shortage. According to the Association of American Medical Colleges, the country could face a shortage of up to 86,000 physicians by 2036, with primary care being one of the most affected areas. Arreaza: Another group that may help address the physician shortage is International Medical Graduates. We'll cover this in more detail in a future episode, but it's worth mentioning briefly here. We have highly trained physicians, including neurosurgeons, driving Uber. There is nothing wrong with that work, but their medical skills could be used to help more people. I'll leave our listeners with that thought: IMGs can help. So, Peyton, are you interested in rural medicine? Peyton: I am very interested in Rural medicine, in fact my next few rotations will be back in South Dakota on the Pine Ridge Indian Reservation. Actually, the Pine Ridge Reservation is the poorest Indian Reservation in the country.  Peyton: The measure of any healthcare system is not how well it serves those closest to its centers of power, but how far its reach extends to those who need it most. If we are serious about health equity, the road forward must run through every small town, every county clinic, and every community that has been told to wait its turn. Their turn is now. References Association of American Medical Colleges (AAMC). The Complexities of Physician Supply and Demand: Projections From 2021 to 2036. https://www.aamc.org/workforce American Academy of Family Physicians (AAFP). Rural Practice and Physician Recruitment.https://www.aafp.org Centers for Disease Control and Prevention (CDC). Rural Americans at Higher Risk of Death from Five Leading Causes.https://www.cdc.gov/media/releases/2017/p0112-rural-death-risk.html Cecil G. Sheps Center for Health Services Research. Rural Hospital Closures.https://www.shepscenter.unc.edu/programs-projects/rural-health/rural-hospital-closures/ Chetty R, Stepner M, Abraham S, et al. The Association Between Income and Life Expectancy in the United States, 2001–2014. JAMA. 2016;315(16):1750–1766. https://jamanetwork.com/journals/jama/fullarticle/2513561 Health Resources & Services Administration (HRSA). Health Professional Shortage Areas (HPSAs).https://data.hrsa.gov/topics/health-workforce/shortage-areas Rural Health Information Hub. Healthcare Access in Rural Communities.https://www.ruralhealthinfo.org/topics/healthcare-access Rural Health Information Hub. Transportation to Support Rural Healthcare.https://www.ruralhealthinfo.org/topics/transportation Rural Health Information Hub. Rural Residency Planning and Development. https://www.ruralhealthinfo.org/topics/rural-residency-programs Centers for Disease Control and Prevention (CDC). Health and Access to Care in Rural America.https://www.cdc.gov/ruralhealth/index.html Measure of America. A Portrait of Los Angeles County 2026. Social Science Research Council.https://ssrc-static.s3.amazonaws.com/moa/APortraitofLosAngelesCounty2026.pdf Merritt Hawkins. Survey of Physician Appointment Wait Times and Medicare and Medicaid Acceptance Rates.https://www.merritthawkins.com/news-and-insights/thought-leadership/survey/survey-of-physician-appointment-wait-times/ Fenster, T. L., MD, Park, J., PhD, Huffstetler, A. N., MD, & Topmiller, M., PhD (2026). Graduate Medical Education Funding Does Not Flow to Primary Care Physician Production. American family physician, 113(4), 321–322. https://pubmed.ncbi.nlm.nih.gov/42101593/ Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/. Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week!

865. The USDA unveiled the 2025–2030 Dietary Guidelines for Americans, and the "Inverted Pyramid" has been sparking a lot of discussion. After a decade of MyPlate, why is the government returning to a pyramid visual—and why is it upside down?In this episode, Monica breaks down the major shifts in the new US guidance, including:The protein pivot: Why protein is taking center stage and what it means for your health.The plant-based omission: Why beans and legumes were left out of the new visuals despite the scientific evidence.The global gap: How the new US pyramid compares to the UK's Eatwell Guide and Canada's food plate.AHA vs. USDA: Why the American Heart Association is issuing its own "course correction" on salt and saturated fat.This episode will help you navigate these changes without losing sight of common-sense nutrition.Nutrition Diva is a Quick and Dirty Tips podcast, hosted by Monica Reinegal.New to Nutrition Diva? Check out our special Spotify playlist for a collection of the best episodes curated by our team and Monica herself! We've also curated some great playlists on specific episode topics including Staying Strong as We Age, Diabetes, Weight Loss That Lasts and Gut Health! Also, find a playlist of our bone health series, Stronger Bones at Every Age. Have a question for Nutrition Diva? Email: nutrition@quickanddirtytips.comFind Monica at wellnessworkshere.comDiscover more from Nutrition Diva:Facebook LinkedInNewsletterTranscripts available at QuickandDirtyTips.com. Hosted on Acast. See acast.com/privacy for more information.

CardioNerds Dr. Joseph Kassab, Dr. Mariana Garcia-Arango, and Dr. Christopher Mason explore the technological revolution of Coronary CT Angiography (CCTA) with expert faculty Dr. Michael Gallagher. The discussion details how CCTA has evolved into a frontline diagnostic and preventive tool, moving beyond simple anatomy to incorporate physiology via CT-FFR and biology through AI-driven plaque quantification. The episode reviews landmark evidence like the SCOT-HEART and PROMISE trials, the nuances of CAD-RADS 2.0 reporting, and the emerging role of AI in monitoring treatment response and personalizing cardiovascular care. Critically, they also discuss some of the assumptions and limitations of these techniques. Stay tuned for a matching review article to be submitted to US Cardiology Review, the official Journal of CardioNerds. This episode was supported by an independent medical education grant from HeartFlow. All CardioNerds education is planned, produced, and reviewed solely by CardioNerds.  Enjoy this Circulation Paths to Discovery article to learn more about the CardioNerds mission and journey. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscripts here. CardioNerds Multimodality Cardiovascular Imaging PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll Pearls Shift in Paradigm: CCTA is no longer just an anatomic test; with some key limitations, it can provide anatomy, physiology (CT-FFR), and plaque biology (AI-CPA) in a single non-invasive scan. The “Power of Zero” vs. Plaque: While a normal CCTA has a >95% negative predictive value, future MIs often arise from non-obstructive plaque that traditional stress tests might miss. CAD-RADS 2.0 Utility: The addition of plaque burden modifiers (P1–P4) is a “game changer,” allowing clinicians to identify high-risk patients who need aggressive lipid-lowering despite having only mild stenosis. CT-FFR as a Virtual Stress Test: CT-FFR uses computational fluid dynamics to simulate blood flow, potentially reducing unnecessary invasive catheterizations by approximately 61% without sacrificing safety. Seeing the Invisible: AI-based quantitative plaque analysis (QCPA) can identify “subvisual” plaque and low-attenuation (lipid-rich) components that are the primary drivers of acute coronary syndromes. Show Notes How has the role of CCTA changed compared to traditional functional testing? Historically, stress testing answered “is there ischemia today?”, which often reflects late-stage disease. CCTA identifies disease across the entire spectrum, asking “is there atherosclerosis and how much plaque is present?”. Landmark evidence: SCOT-HEART showed a 41% relative risk reduction in MI at 5 years attributed to intensified preventive therapies, and PROMISE showed CCTA was better at selecting patients who truly needed invasive angiography. Diagnostic CCTA imaging depends on the protocol, contrast timing, heart rate, heart rhythm, breathholding, scanner quality, and several patient factors (obesity, prior stents, heavy calcification, complex bypass anatomy, and motion artifact all may limit imaging). “CCTA is exceptional for the right patient, with the right scanner, and the right team.” What are the key modifiers introduced in CAD-RADS 2.0, and why do they matter? CAD-RADS 2.0 moved beyond stenosis severity to include plaque burden (P0 to P4), high-risk plaque (HRP) features, and the presence of ischemia based on CT-FFR. It serves as a clinical decision support tool: a patient with mild (25-49%) stenosis but “extensive” (P4) plaque burden is considered high risk and warrants aggressive risk factor modification. How is CT-FFR calculated, and when is it most useful in clinical practice? CT-FFR uses resting CCTA data and computational fluid dynamics to create a 3D model of coronary flow during simulated maximal hyperemia. It is often used for intermediate lesions (40–90% stenosis) to predict if they are  ischemia-producing, guiding the decision whether to proceed with invasive angiography.  The assumptions necessary for this computational modeling may not apply well to patients with microvascular dysfunction, significant myocardial scar or prior infarction, or ventricular hypertrophy. Still, data indicate that CT-FFR performs similarly to PET in predicting hemodynamically significant lesions.  CT-FFR performs well at the extremes (either clearly normal or clearly abnormal). Accuracy dips, however, in the intermediate range (~0.75-0.80), where decision-making is most critical. In this grey zone, additional factors can help guide the approach, including the amount of myocardium supplied, translesional gradient, and plaque features.   CT-FFR has not been validated in distal segments, stented segments, heavily calcified coronary arteries, or in patients with severe aortic stenosis. Caution with CT-FFR should be utilized in very calcified coronary segments.  What is AI-based quantitative plaque analysis (QCPA), and what metrics are ready for clinical use? This is potentially a paradigm shift, moving away from stenosis-centric thinking to a more disease burden and plaque biology focus. QCPA uses deep learning algorithms to automatically segment the vessel wall and quantify plaque volume in mm³. Ready for “prime time” metrics include: Total Plaque Volume (TPV), non-calcified plaque volume, and Low-Attenuation Plaque (LAP) burden. Can serial CCTA be used to monitor the effectiveness of medical therapies like statins? While not yet a routine guideline-driven practice, trials like PARADIGM and EVAPORATE show that therapies can stabilize plaque; notably, CCTA is better for monitoring than CAC scores, which can be misleading as statins often increase plaque calcification as part of the stabilization process. There are no randomized trials that serial CCTAs improve outcomes. Cost and radiation exposure will be notable limitations. Serial scan timing, scan acquisition and interpretation standardization would be key. Dr. Gallagher notes that we are moving toward a world in which plaque burden may become a “treatment biomarker,” similar to tumor burden in oncology.  References 1. Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies: JACC State-of-the-Art Review. Abdelrahman KM, Chen MY, Dey AK, et al. Journal of the American College of Cardiology. 2020;76(10):1226-1243. doi:10.1016/j.jacc.2020.06.076. 2. Non-Invasive Imaging in Coronary Syndromes: Recommendations of the European Association of Cardiovascular Imaging and the American Society of Echocardiography, in Collaboration With the American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Edvardsen T, Asch FM, Davidson B, et al. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 2022;35(4):329-354. doi:10.1016/j.echo.2021.12.012. 3. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Gulati M, Levy PD, Mukherjee D, et al. Journal of the American College of Cardiology. 2021;78(22):e187-e285. doi:10.1016/j.jacc.2021.07.053. 4. Contemporary, Non-Invasive Imaging Diagnosis of Chronic Coronary Artery Disease. van der Bijl P, Gulati M, Saraste A, et al. Lancet (London, England). 2025;406(10519):2577-2587. doi:10.1016/S0140-6736(25)01586-7. 5. State of the Art: Evaluation and Medical Management of Nonobstructive Coronary Artery Disease in Patients With Chest Pain: A Scientific Statement From the American Heart Association. Slipczuk L, Blankstein R, Bucciarelli-Ducci C, et al. Circulation. 2025;152(23):e443-e466. doi:10.1161/CIR.0000000000001394. 6. Diagnostic Performance of Fractional Flow Reserve Derived From Coronary CT Angiography: The ACCURATE-CT Study. Li C, Hu Y, Jiang J, et al. JACC. Cardiovascular Interventions. 2024;17(17):1980-1992. doi:10.1016/j.jcin.2024.06.027. 7. Clinical Outcomes Based on Coronary Computed Tomography-Derived Fractional Flow Reserve and Plaque Characterization. Sato Y, Motoyama S, Miyajima K, et al. JACC. Cardiovascular Imaging. 2024;17(3):284-297. doi:10.1016/j.jcmg.2023.07.013. 8. Clinical Use of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve: Expert Consensus by an International Working Group. Tang CX, Leipsic JA, Nørgaard BL, et al. European Radiology. 2026;:10.1007/s00330-025-12313-6. doi:10.1007/s00330-025-12313-6. 9. Diagnostic accuracy of computed tomography–derived fractional flow reserve: a systematic review. Cook CM, Petraco R, Shun-Shin MJ, et al. JAMA Cardiol. 2017;2(7):803-810. Doi:10.1001/jamacardio.2017.1314 10. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). Nørgaard BL, Leipsic J, Gaur S, et al. J Am Coll Cardiol. 2014;63(12):1145-1155. Doi:10.1016/j.jacc.2013.11.043 11. Comparison of coronary computed tomography angiography, fractional flow reserve, and perfusion imaging for ischemia diagnosis. Driessen RS, Danad I, Stuijfzand WJ, et al. J Am Coll Cardiol. 2019;73(2):161-173. Doi:10.1016/j.jacc.2018.10.056. 12. 1-year outcomes of FFRCT-guided care in patients with suspected coronary disease: the PLATFORM study. Douglas PS, De Bruyne B, Pontone G, et al. J Am Coll Cardiol. 2016;68(5):435-445. Doi:10.1016/j.jacc.2016.05.057. 13. Comparison of an initial risk-based testing strategy vs usual testing in stable symptomatic patients with suspected coronary artery disease: the PRECISE randomized clinical trial. Douglas PS, Nanna MG, Kelsey MD, et al; PRECISE Investigators. JAMA Cardiol. 2023;8(10):904-914. Doi:10.1001/jamacardio.2023.2595. 14. Diagnostic and clinical value of FFRCT in stable chest pain patients with extensive coronary calcification: the FACC study. Mickley H, Veien KT, Gerke O, et al. JACC Cardiovasc Imaging. 2022;15(6):1046-1058. doi:10.1016/j.jcmg.2021.12.010. 15. Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART). Williams MC, Kwiecinski J, Doris M, et al. Circulation. 2020;141(18):1452-1462. doi:10.1161/CIRCULATIONAHA.119.044720. 16. AI-Guided Quantitative Plaque Staging Predicts Long-Term Cardiovascular Outcomes in Patients at Risk for Atherosclerotic CVD. Nurmohamed NS, Bom MJ, Jukema RA, et al. JACC. Cardiovascular Imaging. 2024;17(3):269-280. doi:10.1016/j.jcmg.2023.05.020. 17. Interaction of AI-Enabled Quantitative Coronary Plaque Volumes on Coronary CT Angiography, FFRCT, and Clinical Outcomes: A Retrospective Analysis of the ADVANCE Registry. Dundas J, Leipsic J, Fairbairn T, et al. Circulation. Cardiovascular Imaging. 2024;17(3):e016143. doi:10.1161/CIRCIMAGING.123.016143. 18. Prognostic Value of AI-Based Quantitative Coronary CTA vs Human Reader-Based Visual Assessment: Results From the CONFIRM2 Registry. van Rosendael A, Nakanishi R, Bax JJ, et al. JACC. Cardiovascular Imaging. 2026;19(3):345-359. doi:10.1016/j.jcmg.2025.09.021.13. Pericoronary Adipose Tissue as a Marker of Cardiovascular Risk: JACC Review Topic of the Week. Tan N, Dey D, Marwick TH, Nerlekar N. Journal of the American College of Cardiology. 2023;81(9):913-923. doi:10.1016/j.jacc.2022.12.021. 19. Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: Final Results of the EVAPORATE Trial. Budoff MJ, Bhatt DL, Kinninger A, et al. European Heart Journal. 2020;41(40):3925-3932. doi:10.1093/eurheartj/ehaa652. 20. Coronary CT Angiography Evaluation With Artificial Intelligence for Individualized Medical Treatment of Atherosclerosis: A Consensus Statement From the QCI Study Group. Schulze K, Stantien AM, Williams MC, et al. Nature Reviews. Cardiology. 2026;23(2):100-115. doi:10.1038/s41569-025-01191-6.

The American Heart Association said seed oils were heart-healthy. Your doctor agreed. For sixty years, that was the end of the conversation. But nobody told you how they're made — or what happens when you heat them. Today we go inside the industrial refining process, the omega-6 to omega-3 imbalance backed by peer-reviewed data, and the 2017 BMJ study that sat unpublished for forty years.

In this episode of HeartDoc VIP, Dr. Joel Kahn breaks down the newly released — but not yet fully published — results from the highly anticipated Triumph-1 study on retatrutide, an investigational weight loss medication that's already generating major buzz in the cardiometabolic world. The reported weight loss results at 80 and 104 weeks are remarkable, with side effects appearing consistent with other medications in this class, including semaglutide and tirzepatide. Dr. Kahn discusses what's known so far, what questions still remain, and why the full peer-reviewed publication is so important before drawing final conclusions on risks and benefits. FDA approval may not be far away. Other topics in this packed episode include the troubling rise in fatal heart attacks among younger adults, a modified Mediterranean diet linked to lower diabetes risk, the connection between food preservatives and heart disease, atrial fibrillation in athletes, nitric oxide's role in brain health, fatty liver disease and cardiovascular risk, and how the American Heart Association's Life's Essential 8 score may predict diabetes risk in women. Thanks to Igennus for sponsoring this episode. Visit their site and use promo code DRKAHN to save on high-quality supplements.

In this Retail Technology Spotlight episode, Chris Walton sits down with Kevin Billings, Vice President of Business Development at Sifter Solutions, to unpack how GLP-1 medications, SNAP legislation, and nutrition focused merchandising are reshaping the future of grocery retail. From state-by-state SNAP restrictions to hyper personalized shopping experiences powered by nutrition data, Kevin explains why retailers can no longer afford to treat food intelligence as a niche capability. Drawing from decades of experience across the American Heart Association, Label Insight, NIQ, and Sifter, Kevin shares how retailers can use product level nutritional data to drive compliance, improve shopper experiences, and prepare for a future where health outcomes increasingly influence merchandising strategy. The conversation also explores how grocers can connect pharmacy, loyalty, and merchandising programs to serve shoppers using GLP-1 medications while differentiating themselves against competitors like Amazon and Walmart. From electronic shelf tags and personalized promotions to Arkansas' statewide SNAP technology rollout, this episode offers a practical look at how retailers can prepare for the next era of food as medicine and nutrition driven retail innovation. Key Topics Covered: • 00:11:36 – How SNAP restriction waivers are changing grocery retail state by state • 00:15:57 – Why retailers need product level nutrition data for compliance and merchandising • 00:18:22 – Inside Arkansas' first statewide SNAP shopper technology initiative • 00:24:25 – Why grocers should already be merchandising for GLP-1 shoppers • 00:31:53 – Kevin's vision for the future of hyper personalized grocery shopping See our past 8 years of wonderful Spotlight Series podcast guests, featuring roughly 200 movers and shakers in retail, by clicking here: https://omnitalk.blog/category/spotlight-series-podcast/ #retailtech #groceryretail #GLP1 #foodasmedicine #SNAP #retailinnovation #nutrition #AI #retailoperations #merchandising #loyalty #pharmacy #grocerytech #OmniTalk #retailpodcast *Sponsored Content*

In the first episode of this series on Obesity, our host is joined by Dr. Mikhail Kosiborod to discuss the evolving science and cardiometabolic diseases associated with obesity. This special episode is sponsored with support from AstraZeneca. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Mikhail Kosiborod, MD, Senior Vice President Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D at AstraZeneca. Selected references: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation October 2023

Today's guest is Debbie Hornor, Senior National Consultant for Charitable Estate Planning in Mission Advancement at the American Heart Association, State Volunteer President for AARP Colorado, and currently in remission after primary angiosarcoma of the breast and reoccurrence. She has spent her career in public health policy work, community health, healthcare quality improvement, and so much more. To say she is dedicated to serving others is an understatement. She brings a deeply personal perspective to her work and volunteerism.We talk about the emotional toll of cancer, finding gratitude and joy and being more present in life, the healing power of nature and laughter, community engagement and sharing stories, and so much more!Resources:Debbie's LinkedIn: Debbie Hornor LinkedInAARP Colorado: AARP ColoradoAARP Article about Debbie: A New State President Champions Living Fully At Every Stage Of LifeFollow:Follow me: https://www.instagram.com/melissagrosboll/My website: https://melissagrosboll.comEmail me: drmelissagrosboll@gmail.com

In this episode of Investor Connect, we welcome John Kim, Managing Director at Aphelion Capital, a healthcare-focused venture firm investing in early and mid-stage medical device and digital health companies. John shares Aphelion's evolution from an evergreen, medical-device-only strategy to a stronger focus on cardiovascular and brain health, including a mission-aligned fund built with the American Heart Association, alongside a smaller home health effort. He discusses how the firm became fully remote after COVID, enabling efficient sourcing and meetings with companies nationwide, and explains what he looks for in opportunities—especially reimbursement pathways, clinical need, capital requirements, and experienced teams. John also covers founder traits tied to performance, improving sentiment around exits and acquisitions, how portfolio construction has shifted toward companies with stronger human data and commercial traction, the challenges of investing in standalone AI without defensibility. Visit Aphelion Capital at www.aphelioncapital.net/ Reach out to at www.linkedin.com/in/john-kim-4316b318/, and on john@aphelioncap.com ________________________________________________________________________ For more episodes from Investor Connect, please visit the site at: http://investorconnect.org Check out our other podcasts here: https://investorconnect.org/ For Investors check out: https://tencapital.group/investor-landing/ For Startups check out: https://tencapital.group/company-landing/ For eGuides check out: https:/_/tencapital.group/education/ For upcoming Events, check out https://tencapital.group/events/ For Feedback please contact info@tencapital.group Please follow, share, and leave a review. Music courtesy of Bensound.

Rep. Allen Chesser is a combat veteran who served more than two decades ago, but he says war is still claiming lives today. With veteran suicide continuing to devastate military families, Rep. Chesser joins Skye and Brian for a candid Memorial Day conversation about service, sacrifice, mental health, and why he believes lawmakers must do more to support veterans long after they return home. The Nash County Republican also discusses his own mental fitness, personal discipline, and how he balances public service and family life. Plus, Skye and Brian break down the latest revenue forecast numbers, where budget negotiations currently stand, a growing list of proposed constitutional amendments at the legislature, and the politics of hugging. The Do Politics Better podcast is sponsored by New Frame, the NC Travel Industry Association, the American Heart Association, the NC Pork Council, the NC Realtors, Heal the System NC, and the NC Healthcare Association.

Our guest leads the American Heart Association's initiatives on brain health and brain science, including stroke, aging and dementia, migraine, traumatic brain injury and mental health.

Join Liz Cruz M.D. and Tina Nunziato, Certified Holistic Nutrition Consultant, as they discuss a study that was presented at a recent American Heart Association conference.  Learn about the potential connection between long-term melatonin use and heart failure.  Find out the right dosage for adults and children and what to look out for in melatonin supplements.  Discover other strategies, aside from the popular supplement for better sleep.  Watch us on YouTube:   https://youtu.be/cN8ahsaXC8oDr. Cruz is a Board Certified Gastroenterologist who practices in Phoenix, AZ. Along with her wife Tina Nunziato, a Certified Holistic Nutritionist, they have helped tens of thousands of individuals get well from a more holistic standpoint. They focus on issues such as constipation, diarrhea, acid reflux, heartburn, gas, bloating, food sensitivities, IBS, Crohn's disease, and diverticulitis in addition to a person's general overall health. They do this by teaching about real food, water, digestive enzymes, probiotics, detox, greens, electrolytes, food sensitivity testing, and so much more. If you're struggling with finding the answers to your issues, tired of not feeling well, and sick of taking over the counter and prescription medicines, schedule a FREE 30 minute phone consult at www.drlizcruz.com.

For High Blood Pressure Education Month, our May episode focused on the link between hypertension and high cholesterol, which, together, can significantly raise the risk of heart disease, stroke and other serious illnesses. Our guest Dr. Mary Gover, a general internist at Montefiore Einstein Advanced Care, also shared new cholesterol screening guidelines that have the potential to keep us healthy longer. In our May Key Note, Dr. Gover discusses alternatives to traditional statin treatment that offer more choices for those trying to keep their cholesterol in check.   The Takeaway We want to hear from you! Please complete our survey: org/member-feedback. Drop us a line at our social media channels: Facebook// Instagram // YouTube. Get started on your health journey by making an appointment with your primary care physician to know your numbers. Get to know your numbers at 1199SEIUBenefits.org/healthyhearts. Find healthy recipes and meal-prep tips at 1199SEIUBenefits.org/food-as-medicine. Visit the Healthy Living Resource Center for wellness tips, information and resources; 1199SEIUBenefits.org/healthyliving. For more information on the new cholesterol guidelines, visit the American Heart Association website. Get inspired by fellow members through our Members' Voices series: 1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to join webinars on building healthy meals, managing stress and more: 1199SEIUBenefits.org/videos. Visit our YouTube channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists. Sample our wellness classes to exercise body and mind: 1199SEIUBenefits.org/wellnessevents.   Guest Bio Mary Gover, MD, is a general internist with Montefiore Einstein Advanced Care. Dr. Gover received her medical degree from Columbia University Vagelos College of Physicians and Surgeons. She completed her Internal Medicine residency with a focus on primary care at Montefiore Einstein and served as chief resident for that program. Dr. Gover has held leadership roles in medical education and practice administration. Above all else, Dr. Gover is passionate about patient care. She believes not only in the importance of clinical excellence and expertise but also in collaboration and partnership. She is certified in health coaching through Wellcoaches, with the aim of furthering patients' personal health goals and overall wellness.

Former Rep. Leo Daughtry joins Skye and Brian to reflect on his storied political career, including the dramatic battle for Speaker of the North Carolina House heading into the 2003–2004 biennium. For weeks, the Johnston County Republican was widely viewed as the next Speaker after his party narrowly won the NC House in 2002 by a single seat.   But, a last-minute revolt within the Republican caucus stripped away the votes he needed and denied him the gavel on the opening day of session. The political fallout fractured House Republicans for years and remains one of the most talked-about leadership fights in modern North Carolina political history. Plus, the podcast breaks down the celebrated announcement of a budget deal, movement on an ABC reform bill in the House, a new John Locke Foundation poll, TOTW, and more. The Do Politics Better podcast is sponsored by New Frame, the NC Travel Industry Association, the American Heart Association, the NC Pork Council, the NC Realtors, Heal the System NC, and the NC Healthcare Association.

Joanne Alves e Nordman Wall convidam Caroline Millon para discutir a abordagem da Síndrome de Apneia e Hipopneia Obstrutiva do Sono (SAHOS). Referências: Myers, Kathryn A et al. “Does this patient have obstructive sleep apnea?: The Rational Clinical Examination systematic review.” JAMA vol. 310,7 (2013): 731-41. doi:10.1001/jama.2013.276185Gawrys, Breanna et al. “Obstructive Sleep Apnea in Adults: Common Questions and Answers.” American family physician vol. 110,1 (2024): 27-36.Hong, Yanan et al. “The study of the relationship between moderate to severe sleep obstructive apnea and cognitive impairment, anxiety, and depression.” Frontiers in neurology vol. 15 1363005. 10 May. 2024, doi:10.3389/fneur.2024.1363005US Preventive Services Task Force et al. “Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement.” JAMA vol. 328,19 (2022): 1945-1950. doi:10.1001/jama.2022.20304Palombini, Luciana de Oliveira. “Critérios diagnósticos e tratamento dos distúrbios respiratórios do sono: RERA” [Diagnostic criteria and treatment for sleep-disordered breathing: RERA]. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia vol. 36 Suppl 2 (2010): 19-22. doi:10.1590/s1806-37132010001400007Yeghiazarians, Yerem et al. “Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association.” Circulationvol. 144,3 (2021): e56-e67. doi:10.1161/CIR.0000000000000988Duarte, Ricardo Lm et al. “Obstructive Sleep Apnea Screening with a 4-Item Instrument, Named GOAL Questionnaire: Development, Validation and Comparative Study with No-Apnea, STOP-Bang, and NoSAS.” Nature and science of sleep vol. 12 57-67. 23 Jan. 2020, doi:10.2147/NSS.S238255Gottlieb, Daniel J, and Naresh M Punjabi. “Diagnosis and Management of Obstructive Sleep Apnea: A Review.” JAMA vol. 323,14 (2020): 1389-1400. doi:10.1001/jama.2020.3514Malhotra, Atul et al. “Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity.” The New England journal of medicine vol. 391,13 (2024): 1193-1205. doi:10.1056/NEJMoa2404881

Discover the secret to removing poisons with my Detox Decoded Masterclass! https://hayliepomroy.com/detox  In this episode, I'm excited to be joined by Dr. Farzanna Haffizulla, President-elect of the American Heart Association in South Florida. Together, we discuss important topics around women's health, focusing on how to prevent health issues and make lasting changes in our well-being. We explore the six pillars of lifestyle medicine: exercise, nutrition, sleep, stress resilience, social connections, and avoiding harmful habits. Dr. Haffizulla gives tips on how to incorporate these into your daily life, from simple ways to move more to healthier eating choices.  We even chat about her cooking show, where she transforms traditional recipes into healthier versions without losing the flavors we love. This episode is full of helpful tips to take control of your health and feel better every day. If you're looking for practical ways to improve your well-being, you'll enjoy this conversation!   If your body feels like it's running on empty, overburdened, or just not responding the way it used to, Haylie's latest book, Toxic Overload, tells you exactly what to do. Download your free digital copy today and start understanding what your body is trying to tell you.   Free Download: Get Your Copy of Toxic Overload

Rep. Stephen Ross is wrapping up an incredible political career that began in Burlington, where he served on the City Council, led as Mayor, and eventually was persuaded to run for the NC House. The Alamance County Republican shares how he worked alongside a fellow mayor from another county (and another political party) to deliver results not just for their hometowns, but for North Carolina politics as a whole. But the most powerful moment comes when Rep. Ross reflects on his late mother. After his father died of a stroke while Rep. Ross was still in high school, she found herself rebuilding a family from the ground up after the family business was lost. Her determination didn't just keep the family afloat, it inspired achievement, resilience, and purpose for Rep. Ross and his siblings. It's a moving conversation ahead of Mother's Day weekend. Plus, Skye and Brian break down the week in #ncpol, including a property tax bill on the move, two members of Congress land in hot water, Rep. Budd battles breast cancer, and North Carolina loses a former lawmaker.   The Do Politics Better podcast is sponsored by New Frame, the NC Travel Industry Association, the American Heart Association, the NC Pork Council, the NC Realtors, Heal the System NC, and the NC Healthcare Association.

Meme Stokes Callnin had spent two decades inside global human capital consulting building talent strategies, advising on M&A integrations, and leading the Mountain States for Mercer across all things human capital. Then she went to a Harvard executive program on women in the boardroom. And everything shifted. She came back with a clear mission. 2024 was going to be her year. Then she hit the wall: her firm didn't allow paid board seats. Within months, the pieces fell into place. She raised her hand for a package, walked out, and entered what she calls her "rewirement." Today, Meme Stokes Callnin is an independent board director and growth strategist, sitting on the boards of Select Health, Wonderbound, and the American Heart Association's Colorado Go Red for Women campaign, which she chaired in 2024. She has helped raise over $1 million for the AHA, driven by a single realization at a breakfast back in 2018: women's heart attack symptoms are different from men's, and most women don't know it. In this episode of Inspiring Women, host Laurie McGraw sits down with Meme at the WBL Summit to trace the full arc, from corporate executive to professional board director, and unpack what it actually takes to land a seat in a room that doesn't post its openings. They discuss: The 2018 American Heart Association breakfast that pulled her in for good, and the survivor story that made her realize women's heart attack symptoms differ from men's, and that despite heart disease running in her family, she'd never been told Why women are dangerously underserved when it comes to CPR, and her blunt take: "I'd rather live than worry about a broken rib" The Harvard executive program that flipped the switch, and why "rewirement" is her word for what most people would call retirement Her honest read on the post-DEI slowdown in the boardroom, what's changed, what hasn't, and why advocacy for women still matters The "secret club" of board recruiting, why the big executive search firms won't place you on a public board until you've already got one, and what to do about it Her 5 Fs framework, Family, Financial, Fitness, Fun, Faith, and how she uses it to filter every meeting, every coffee, every yes Why she chose healthcare as her board focus, drawing on sandwich-generation experience and decades of consulting across the ecosystem Her core advice for women seeking their first board seat: be bold about what you know, make the direct ask, and raise your hand often Meme Stokes Callnin is proof that "rewirement" isn't slowing down. It's choosing, with intention, exactly what the next chapter looks like, and then asking for it out loud.

For High Blood Pressure Education month, we're dedicating our May episode to both this condition – which affects nearly half of all adults in the U.S – and high cholesterol. Why both? When combined, they significantly raise the risk of heart disease, stroke and other serious illnesses. So, we're happy to welcome Dr. Mary Gover, a general internist at Montefiore Einstein Advanced Care, to help us understand the connection between high blood pressure and high cholesterol and offer steps we can take to successfully manage – or prevent – both conditions. Dr. Gover also explains the new guidelines recently issued for cholesterol and shares treatment options that range from healthy lifestyle changes to medication to a combination of the two. The Takeaway We want to hear from you! Please complete our survey: org/member-feedback. Drop us a line at our social media channels: Facebook// Instagram // YouTube. Get started on your health journey by making an appointment with your primary care physician to know your numbers. Get to know your numbers at 1199SEIUBenefits.org/healthyhearts. Find healthy recipes and meal-prep tips at 1199SEIUBenefits.org/food-as-medicine. Visit the Healthy Living Resource Center for wellness tips, information and resources; 1199SEIUBenefits.org/healthyliving. For more information on the new cholesterol guidelines, visit the American Heart Association website. Get inspired by fellow members through our Members' Voices series: 1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to join webinars on building healthy meals, managing stress and more: 1199SEIUBenefits.org/videos. Visit our YouTube channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists. Sample our wellness classes to exercise body and mind: 1199SEIUBenefits.org/wellnessevents.   Guest Bio Mary Gover, MD, is a general internist with Montefiore Einstein Advanced Care. Dr. Gover received her medical degree from Columbia University Vagelos College of Physicians and Surgeons. She completed her Internal Medicine residency with a focus on primary care at Montefiore Einstein and served as chief resident for that program. Dr. Gover has held leadership roles in medical education and practice administration. Above all else, Dr. Gover is passionate about patient care. She believes not only in the importance of clinical excellence and expertise but also in collaboration and partnership. She is certified in health coaching through Wellcoaches, with the aim of furthering patients' personal health goals and overall wellness.

Walking into a cardiologist appointment is more often than not walking into a time machine. Not only the discussions about disproven risks but unfortunately the outdated tools and technology that have little to no predictive or preventative potential. The worst part is the technology exists that can identify to the microscopic level the type of plague actually causal to more than 80% of heart-attacks! That's what Dr Osborne and ClearCardio are doing right now.Dr. John Osborne is a cardiologist and the founding director of State of the Heart Cardiology, with a strong focus on preventive and non-invasive cardiovascular care. He holds an M.D. magna cum laude, a Ph.D. in cardiovascular physiology, and completed postdoctoral training at Harvard Medical School and Brigham and Women's Hospital. Uniquely board-certified across multiple disciplines, his work spans metabolic health, cardiovascular genetics, and advanced cardiac imaging. Dr. Osborne has received the American Heart Association's Cardiac Care Provider of the Year award. He is also the founder of ClearCardio™, where he is advancing proactive heart health through the use of AI-driven diagnostics and personalized care.Contact:Youtube - https://www.youtube.com/@ClearCardioWebsite - https://clearcardio.comJoin us as we explore:Why EKGs and CAC scores offer far less than advertised.Why so much that happens in a cardiologists office are 20th century tools, and why ClearCardio's cutting-edge AI biotech offers lifesaving  preventative potential.AI's ability to identify and quantify plague  to the 10th of a cubic millimeter!CT vs MR, the different types of arterial plague (hard, soft, lipid rich, active) , why 86% of heart attacks will never show up on your CAC scoreWhy strokes and heart disease are far more connected than appreciated, and how the cholesterol story has misguided us.Why blood markers like hsCRP are far more critical to understanding cardiovascular disease than even I appreciated.MentionsProduct - OMRON, https://omronhealthcare.com/products/evolv-wireless-upper-arm-blood-pressure-monitor-bp7000Test - Cleerly, https://cleerlyhealth.comSupport the showFollow Steve's socials: Instagram | LinkedIn | YouTube | Facebook | Twitter | TikTokSupport the show on Patreon:As much as we love doing it, there are costs involved and any contribution will allow us to keep going and keep finding the best guests in the world to share their health expertise with you. I'd be grateful and feel so blessed by your support: https://www.patreon.com/MadeToThriveShowSend me a WhatsApp to +27 64 871 0308. Disclaimer: Please see the link for our disclaimer policy for all of our content: https://madetothrive.co.za/terms-and-conditions-and-privacy-policy/

Thanks For Listening! LEAVE A REVIEW OF THE SHOW: There is nothing more appreciated to a podcast than leaving a written review and 5-Star Rating. Please consider taking 1-2 minutes to do that (iTunes). You can also leave a review on SPOTIFY! RESOURCES/COACHING: Join TEAM NATTYHOUR at www.thenattyhour.com/apply SOCIAL LINKS: Follow Krysten Janzen on YouTube Follow @krysten.janzen on Instagram Follow @krysten.janzen on Twitter Follow Krysten Janzen on Facebook References Simopoulos, A. P. (2002). The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & Pharmacotherapy, 56(8), 365-379. Discusses the omega-6 to omega-3 ratio and its potential impact on inflammation. Johnson, G. H., & Fritsche, K. (2020). Effect of dietary linoleic acid on markers of inflammation in healthy persons: A systematic review of randomized controlled trials. Advances in Nutrition, 11(3), 697-709. A systematic review finding no evidence that higher omega-6 intake leads to increased inflammation. Ramsden, C. E., Faurot, K. R., Carrera-Bastos, P., et al. (2012). Dietary fat quality and coronary heart disease prevention: A unified theory based on evolutionary, historical, global, and modern perspectives. Nutrition Journal, 11(1), 10. Concludes that replacing saturated fats with polyunsaturated fats, including omega-6s, does not increase inflammation. Sacks, F. M., Lichtenstein, A. H., Wu, J. H., et al. (2017). Dietary fats and cardiovascular disease: A presidential advisory from the American Heart Association. Circulation, 136(3), e1-e23. Recommends replacing saturated fats with polyunsaturated fats (including those from seed oils) for improved heart health. Food and Chemical Toxicology. (2016). Assessment of potential adverse effects of residual solvents in edible vegetable oils. Discusses the safety of trace amounts of hexane in processed seed oils, concluding that they pose no health risk. Lichtenstein, A. H., Appel, L. J., Vadiveloo, M., et al. (2018). Dietary fat intake and cardiovascular disease risk: A scientific statement from the American Heart Association. Journal of the American Heart Association, 7(10), e013620. Examines the relationship between different dietary fats and heart disease risk, finding benefits in consuming polyunsaturated fats over saturated fats.

What if every time you reached for a packaged snack… you were quietly increasing your risk of a heart attack? In this urgent and deeply personal solo episode, Darin breaks down groundbreaking new research showing that each serving of ultra-processed food may increase cardiovascular risk by over 5%, not over time, but every single time you eat it. This isn't about calories. It's about chemistry, biology, and a system engineered for convenience at the expense of your health. From the shocking data to the underlying mechanisms: gut destruction, visceral fat accumulation, brain hijacking, and toxic exposure, this episode exposes the real cost of ultra-processed food and gives you the tools to reclaim control of your health and your life. What You'll Learn The shocking stat: 5% increased heart risk per serving of ultra-processed food Why ultra-processed foods act like compounding debt on your health The difference between calories vs chemical toxicity in food How emulsifiers and additives destroy your gut microbiome Why ultra-processed foods increase visceral fat around your organs How these foods are engineered to override your brain's satiety signals The hidden toxins from processing and packaging (PFAS, bisphenols, AGEs) Why this crisis disproportionately impacts certain communities The truth: you can't "out-exercise" ultra-processed food damage Practical ways to transition back to real, whole foods Chapters 00:00:04 – Opening: SuperLife mission and setting the stage 00:00:33 – Sponsor: Alkemis Paint and hidden indoor toxicity 00:01:24 – Why conventional paints off-gas harmful chemicals for years 00:02:27 – Cradle-to-Cradle certification and non-toxic living 00:03:24 – Entering the episode: the 5% heart risk question 00:03:34 – The shocking claim: every serving increases heart risk 00:04:16 – Ultra-processed food as "compounding debt" 00:05:08 – Leaning into discomfort as a path to growth 00:06:33 – The convenience trap: food delivered instantly 00:07:15 – The real cost: trading time for lifespan 00:08:07 – 2026 study overview (MESA dataset, 6,800 participants) 00:09:01 – 5.1% increased cardiovascular risk per serving explained 00:09:29 – 66.8% higher risk in high-consumption groups 00:10:08 – Risk is independent of calories, weight, and fitness 00:10:56 – "This is not a calorie story—it's a chemistry story" 00:11:10 – Racial disparities and food system inequality 00:12:08 – Additional studies confirm elevated heart risk 00:13:04 – Global meta-analysis: over 1 million participants 00:13:26 – The conclusion: the science is no longer debatable 00:14:18 – Sponsor: Shakeology and nutrient density 00:15:36 – What is ultra-processed food? (NOVA classification) 00:16:18 – Examples: chips, cereals, protein bars, fast food 00:16:57 – "These foods are engineered—not real food" 00:17:00 – Mechanism #1: gut microbiome disruption 00:18:03 – Emulsifiers and inflammation explained 00:18:49 – Gut inflammation triggers systemic disease 00:19:18 – Mechanism #2: visceral fat accumulation 00:19:56 – Why visceral fat is more dangerous than visible fat 00:20:18 – Mechanism #3: brain hijacking and satiety override 00:20:47 – Engineered foods and addictive eating patterns 00:21:04 – Mechanism #4: toxins from processing and packaging 00:21:30 – PFAS, bisphenols, and chemical contamination 00:21:37 – The solution: whole food first 00:22:02 – Breaking habits and reclaiming control 00:22:20 – Simple swaps: fruit, nuts, whole ingredients 00:23:00 – "If you can't trace it back to a real food, put it down" 00:23:32 – Making whole food convenient 00:24:06 – Batch cooking and preparation strategies 00:24:16 – Personal story: losing a friend to diet-related illness 00:24:40 – The emotional reality: this is life or death 00:25:00 – Community support and accountability 00:25:25 – Call to action: share this message 00:25:41 – Closing: courage, awareness, and living a SuperLife 00:26:23 – Outro Thank You to Our Sponsors: Shakeology: Get 15% off with code DARINO1BODI at Shakeology.com. Alkemis Paint: Go to https://alkemispaint.com/ and use code DARIN10 for 10% off your order. Join the SuperLife Patreon: This is where Darin now shares the deeper work: - weekly voice notes - ingredient trackers - wellness challenges - extended conversations - community accountability - sovereignty practices Join now for only $7.49/month at https://patreon.com/darinolien Connect with Darin Olien: Website: darinolien.com Instagram: @darinolien Book: Fatal Conveniences Platform & Products: superlife.com New Show: Roadmap to Happiness Key Takeaway "Every time you reach for ultra-processed food, you're not just making a small decision—you're compounding a biological cost that your body has to pay later. But the moment you become aware, you reclaim your power. Because the same way those choices can slowly take your health away… different choices, repeated daily, can give it all back." Bibliography/Sources Primary Study — News Hook Haidar, A., Rikhi, R., Watson, K. E., Wood, A. C., & Shapiro, M. D. (2026). Association between ultraprocessed food consumption and cardiovascular disease risk: MESA. JACC: Advances. https://doi.org/10.1016/j.jacadv.2025.102516 Supporting Studies — 2026 Willett, Y., Yang, C., Dunn, J., et al. (2026). Consumption of ultra-processed foods and increased risks of cardiovascular disease in U.S. adults. The American Journal of Medicine. https://doi.org/10.1016/j.amjmed.2026.01.012 Systematic Reviews & Meta-Analyses Dose-response meta-analysis: UPF consumption and cardiovascular events risk — 20 studies, 1.1M participants. (2024). eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2024.102480 Ultra-processed foods and cardiovascular disease: Analysis of three large US prospective cohorts and a systematic review and meta-analysis. (2024). The Lancet Regional Health – Americas. https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(24)00186-8/fulltext Mechanisms — Gut, Inflammation & Additives Ultra-processed foods and cardiovascular diseases: Potential mechanisms of action. (2021). Advances in Nutrition. https://pmc.ncbi.nlm.nih.gov/articles/PMC8483964/ Ultra-processed foods and food additives in gut health and disease. (2024). Nature Reviews. https://pubmed.ncbi.nlm.nih.gov/38388570/ Ultra-processed foods and incident cardiovascular disease in the Framingham Offspring Study. (2021). Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2021.01.047 Ultraprocessed foods and their association with cardiometabolic health: A science advisory from the American Heart Association. (2023). Circulation. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001365 Visceral Fat Konieczna, J., et al. (n.d.). Contribution of ultra-processed foods in visceral fat deposition: Prospective analysis nested in the PREDIMED-Plus trial. Clinical Nutrition. https://www.explorationpub.com/Journals/edd/Article/100523 NOVA Classification Monteiro, C. A., Cannon, G., Levy, R. B., et al. (2019). Ultra-processed foods: What they are and how to identify them. Public Health Nutrition, 22(5), 936–941. https://pubmed.ncbi.nlm.nih.gov/30744710/ Policy & Public Health Context American College of Cardiology. (2025). ACC 2025 concise clinical guidance: Front-of-package labeling endorsement. Journal of the American College of Cardiology. U.S. Departments of Agriculture and Health and Human Services. (n.d.). Dietary guidelines for Americans, 2025–2030. https://www.dietaryguidelines.gov General Coverage — News Hook Food Safety Magazine. (2026, April). Study links diets high in ultra-processed foods to increased heart attack, stroke risk. https://www.food-safety.com/articles/11290-study-links-diets-high-in-ultra-processed-foods-to-increased-heart-attack-stroke-risk ScienceDaily. (2026, March). Ultra-processed foods linked to 67% higher risk of heart attack and stroke. https://www.sciencedaily.com/releases/2026/03/260319074604.htm

Senate President Pro Tem Phil Berger sits down for a candid conversation about the legislative short session and the question everyone in #ncpol is asking: Will the House and Senate actually come together on a new budget? Sen. Berger also reflects on his unsuccessful run for the NC House in 1994, his successful bid for NC Senate six years later, and talks about spending a decade in the minority. We also dig into the pivotal 2010 shift to a Republican majority, Berger's perspective on that transition, and his respect for the way his Democratic predecessor, Sen. Marc Basnight, navigated a change in power. Skye and Brian also run through a packed week in #ncpol: another round of party hopping in the House, budget talks, a brewing dispute over access to water, the passing of a former senator, and a deleted #TOTW salvaged. Along the way, there's also a detour into “slippery when wet” signage at the General Assembly.   The Do Politics Better podcast is sponsored by New Frame, the NC Travel Industry Association, the American Heart Association, the NC Pork Council, the NC Realtors, Heal the System NC, and the NC Healthcare Association.

Today, we're diving into a topic that should be getting far more attention: Cardiovascular disease in women. Heart disease is one of the leading causes of death in women—yet it's often under-addressed, oversimplified, and misunderstood in clinical practice. Most women are told: “Eat better. Take this prescription.” But that approach misses something critical. Full citation list:    •    Hall, Kevin D., et al. “Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake.” Cell Metabolism, vol. 30, no. 1, 2019, pp. 67–77.e3. Supports the core causal point that ultra-processed foods drive higher intake and weight gain even under controlled feeding conditions; this is not a women-specific lipid paper, but it is the cleanest experimental anchor for why UPFs create a high-throughput metabolic environment.     •    El Khoudary, Samar R., et al. “Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association.” Circulation, vol. 142, no. 25, 2020, pp. e506–e532. Supports the midlife women's frame: across the menopause transition, LDL-C and ApoB rise, metabolic risk shifts, and cardiovascular prevention needs to become more deliberate during this window. This supports the “why I care about lipids in endocrine care” part of the episode.     •    Derby, Carol A., et al. “Lipid Changes During the Menopause Transition in Relation to Age and Weight: The Study of Women's Health Across the Nation.” American Journal of Epidemiology, vol. 169, no. 11, 2009, pp. 1352–61. Foundational SWAN paper establishing that the menopause transition itself — not just chronological aging — is associated with adverse lipid shifts in midlife women. This is the original observation that the timing argument rests on.     •    Wu, Bingjie, et al. “Trajectories of Blood Lipids Profile in Midlife Women: Does Menopause Matter?” Journal of the American Heart Association, vol. 12, no. 22, 2023, e030388. Supports the claim that LDL-C, total cholesterol, and ApoB follow distinct trajectory patterns through the menopause transition, with subgroups of women showing rising lipids in the years before the final menstrual period — useful for the timing argument that body and symptom changes can precede the obvious lab story.     •    Matthews, Karen A., et al. “Age at Menopause in Relationship to Lipid Changes and Subclinical Carotid Disease Across 20 Years: Study of Women's Health Across the Nation.” Journal of the American Heart Association, vol. 10, no. 18, 2021, e021362. Supports the point that ApoB and Apo A1 changes cluster around the final menstrual period and that adverse lipid shifts in the early postmenopausal years track with subclinical carotid disease later — connects menopausal timing to the longer cardiovascular arc rather than a one-time lab blip.     •    De Oliveira-Gomes, Diana, et al. “Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice.” Circulation, vol. 150, no. 1, 2024, pp. 62–79. Supports the practical ApoB explanation: ApoB reflects atherogenic particle burden and outperforms LDL-C for ASCVD risk prediction in many settings, but adoption lags because clear apoB targets and triggers are still lacking in mainstream guidelines. Good support for the public-service “what the hell is ApoB anyway?” section.     •    Williamson, Laura. “The Slowly Evolving Truth About Heart Disease and Women.” American Heart Association News, 9 Feb. 2024, heart.org/en/news/2024/02/09/the-slowly-evolving-truth-about-heart-disease-and-women. Supports the broader clinical framing that women remain underrecognized or undertreated in cardiovascular care and that women's heart disease still needs better public and clinical communication. This is more public-facing than mechanistic, but useful for your opening frame. Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he's helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He's also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you're ready to take your health seriously, this podcast is a great place to start.

Episode Description: In this episode of the Elevate Yourself podcast, Rob is joined by Laurie Whitsel and Tom from the Physical Activity Alliance to discuss making physical activity a standard part of healthcare. Laurie shares insights from the It's Time to Move campaign, focused on integrating assessment, prescription, and referral into care systems, while Tom highlights the CEO Pledge and how organizations can create movement-friendly workplaces. Together, they explore how healthcare, workplaces, and communities can align to help more people move more often—and what it will take to turn physical activity into a true standard of care. Guest Bio: Laurie Whitsel, Ph.D. is currently the Vice President of Policy Research and Translation for the American Heart Association, helping to translate science into policy at a national level in the areas of cardiovascular disease and stroke prevention and health promotion. LinkedIn https://www.linkedin.com/in/laurie-whitsel-ph-d-faha-bb4b688/ Tom Richards is the Director of Engagement at the Physical Activity Alliance, where he leads national efforts to build partnerships and advance initiatives that promote physical activity across healthcare, workplaces, and communities. In this role, he supports campaigns like the CEO Pledge for Physical Activity, helping organizations adopt movement-friendly strategies that enhance health and productivity.Tom also serves as Principal of Old Stone Nonprofit Advisory, where he provides strategic planning, partnership development, and growth consulting to mission-driven organizations. Prior to his current roles, he was Director of Stakeholder Engagement at the American Council on Exercise (ACE), where he helped strengthen connections across the health and fitness industry. LinkedIn https://www.linkedin.com/in/thomas-richards1122/ Resources Discussed Physical Activity Alliance https://paamovewithus.org/ It's Time to Move Campaign https://paamovewithus.org/its-time-to-move/ CEO Pledge https://paamovewithus.org/about-the-pledge/ Sign The CEO Pledge https://paamovewithus.org/sign-the-pledge/ Physical Activity Fast Facts https://paamovewithus.org/resource/physical-activity-fast-facts/ *Fact Check Correction: The Cost Estimate of Healthcare expenditures is $192 Billion https://journals.sagepub.com/doi/full/10.1177/08901171251357128 and https://journals.lww.com/acsm-tj/pages/articleviewer.aspx?year=2025&issue=07180&article=00005&type=Fulltext Physical Activity Alliance https://paamovewithus.org/ It's Time to Move Campaign https://paamovewithus.org/its-time-to-move/ CEO Pledge https://paamovewithus.org/about-the-pledge/ Sign The CEO Pledge https://paamovewithus.org/sign-the-pledge/ Physical Activity Fast Facts https://paamovewithus.org/resource/physical-activity-fast-facts/ *Fact Check Correction: The Cost Estimate of Healthcare expenditures is $192 Billion https://journals.sagepub.com/doi/full/10.1177/08901171251357128 and https://journals.lww.com/acsm-tj/pages/articleviewer.aspx?year=2025&issue=07180&article=00005&type=Fulltext The Elevate Yourself Podcast is brought to you in partnership with Athletic Brewing. Use code ELEVATE30 for 30% OFF your first online order at checkout! https://athleticbrewing.com/

Murphy Jensen is the co-founder and EVP of WEconnect Health, a Seattle based healthcare company that provides support & services through a mobile application to people suffering from substance mis-use and mental health disorders.After years of playing professional tennis (winning the French Open Doubles) Murphy hosted TV-shows Open Access  and Murphy's Guide on the Tennis Channel. Using the game of tennis to support his favorite causes, Murphy participates in events like the Prostate Cancer Foundation Pro-Am and Chris Evert's Celebrity Classic.  Lending his infectious positive attitude and genuine love the of the game, Murphy brings fun wherever he goes.Surviving a Sudden Cardiac Arrest in Oct 2021, Murphy was saved by an on-site AED & CPR. Murphy is a spokesman for the American Heart Association and partner in the Gootter-Jensen Foundation. The continued recovery from his cardiac event and the traumatic brain injury he suffered when he collapsed, have added a new layer to Murphy's advocacy for mental health awareness.Murphy is known as one of the most entertaining people in tennis, reminding people that tennis is supposed to be fun.  Breaking down walls and finding a human connection is as much a part of finding success in the game of tennis as a forehand or backhand.

Speaker Destin Hall previews the short session now underway and breaks down the path forward on the state budget after last year's budget stalemate.  The Speaker walks listeners through his priorities, what's changed since last year, and whether there's a realistic path to breaking the impasse. He also reflects on his first year holding the gavel:  what he's learned, his leadership style, and he talks about "the Schedule". Plus, Skye and Brian run through a packed week: first-day-of-session vibes, the latest on Medicaid rebasing, where budget negotiations stand, and Governor Josh Stein rolling out his proposed budget.  We also hit the formation of a new investigative committee, the swearing-in of three new legislators, a few early session predictions, how AI is creeping into policymaking conversations, and plenty more from around Jones Street. The Do Politics Better podcast is sponsored by New Frame, the NC Travel Industry Association, the American Heart Association, the NC Pork Council, the NC Realtors, Heal the System NC, and the NC Healthcare Association.

In October 2023, the American Heart Association officially admitted something that changes everything: heart disease, kidney disease, and diabetes are not separate conditions — they're one syndrome. CKM syndrome. And 90% of US adults already have it.CHAPTERS:00:00 — 90% of Americans have this condition01:02 — Part 1: What CKM syndrome actually is01:20 — AHA Presidential Advisory: the 2023 definition01:48 — The 4-stage system (Stage 0 through 4)02:38 — JAMA 2024: only 10.6% are Stage 003:15 — 49% are Stage 2 — greatest opportunity for reversal03:38 — Part 2: Why the AHA created it now04:06 — Stage 3: 3x all-cause mortality, 7x cardiovascular mortality04:40 — 45.3% of all cardiovascular deaths are CKM-attributable05:26 — The disease starts silently in your 20s06:10 — Part 3: The root cause finally acknowledged06:22 — Stage 1 = dysfunctional adiposity, not high cholesterol07:41 — HOMA-IR meta-analysis: 64% higher CAD risk, 76% stroke risk08:09 — Part 4: The vindication09:20 — The blind spot: AHA stages disease but won't say how to reverse it09:47 — Part 5: What you can actually do10:42 — Reduce processed food, TRE, walking, sleepREFERENCES:AHA Presidential Advisory on CKM (Circulation, 2023): AHA.orgCKM Prevalence in US Adults (Khan et al., JAMA, 2024): JAMACKM and Mortality NHANES Study (Am J Prev Cardiology, 2025): PMC12003006AHA 2026 Statistics Update: pubmed/41562125HOMA-IR and CVD Meta-Analysis 65 Studies (PLoS ONE, 2012): PMC3532497HOST: Dr. Robert Lufkin MD | robertlufkinmd.com | Lies I Taught in Medical School⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!New episodes every Tuesday & Thursday. Subscribe so you don't miss one.Continue this conversation on Substack: https://robertlufkinmd.substack.comLies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/Web: https://www.robertlufkinmd.comYouTube: https://www.youtube.com/robertlufkinmdX: https://x.com/robertlufkinmdInstagram: https://www.instagram.com/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinLinkedIn: https://www.linkedin.com/in/robertlufkinmd/

Fatty acids remain one of the most debated areas in clinical nutrition, yet many widely held beliefs may not align with current evidence. In this episode of New Frontiers in Functional Medicine, Dr. Kara Fitzgerald sits down with Bill Harris, PhD, Founder of OmegaQuant Analytics and co-inventor of the Omega-3 Index, to examine the role of omega-3 and omega-6 fatty acids in cardiovascular risk and clinical decision-making. Learn how to use the Omega-3 Index as a biomarker, interpret atrial fibrillation risk in the context of omega-3 intake, and differentiate between pharmaceutical and dietary interventions. The conversation also explores emerging data on linoleic acid, challenges simplified “good vs bad fat” models, and highlights the complexity of fatty acid metabolism—offering practical guidance for evaluating labs and refining nutrition strategies in practice. Full show notes + references: https://www.drkarafitzgerald.com/fxmed-podcast/ GUEST DETAILS Dr. Bill Harris, PhD is a leading omega-3 researcher with over 40 years of experience and more than 400 publications on fatty acids and health. He is the co-inventor of the Omega-3 Index and founder of OmegaQuant Analytics. Dr. Harris has held faculty positions at three medical schools, received NIH funding for omega-3 research, and co-authored American Heart Association statements on fatty acids and heart health. He is ranked among the top 2% of scientists worldwide for research impact. Email: wsh@faresinst.com https://omegaquant.com/ https://www.faresinst.org/ THANKS TO OUR DIAMOND SPONSORS Biotics Research: https://www.bioticsresearch.com/ Time—Line Nutrition: http://pro.timeline.com/ DUTCH: https://dutchtest.com/for-providers CONNECT with DrKF Want more? Join our newsletter here: https://www.drkarafitzgerald.com/newsletter/ Or take our pop quiz and test your BioAge! https://www.drkarafitzgerald.com/bioagequiz YouTube: https://tinyurl.com/hjpc8daz Instagram: https://www.instagram.com/drkarafitzgerald/ Facebook: https://www.facebook.com/DrKaraFitzgerald/ DrKF Clinic: Patient consults with DrKF physicians including Younger You Concierge: https://tinyurl.com/yx4fjhkb Younger You Practitioner Training Program: www.drkarafitzgerald.com/trainingyyi/ Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw

In this episode, Steve Yurjevich, Chief Executive Officer of Optum Insight's Payer Market and a member of the American Heart Association Executive Leadership Team, joins the podcast to discuss rising healthcare costs and the growing adoption of AI across the payer landscape. He shares how the industry is shifting from pre-pay models to true avoidance strategies, focusing on preventing unnecessary care and improving overall system efficiency.

Expect a renewed push to take a statin at your next doctor's visit; PREVENT online calculator skews decisions to prescribe cholesterol reduction as early as 30; American Heart Association discourages at-risk patients from taking fish oil and garlic supplements—REALLY? Renewed interest in muscle as promoter of overall health and metabolism; The key role of urolithin A (Mitopure®️) for supporting muscle function. Is DHEA a reasonable supplement for post-menopausal women?

TV Guide called her “the most famous soap opera character in the history of daytime TV.” Actor Susan Lucci inhabited the role of bad girl Erica Kane on ABC’s “All My Children” for four decades, from the show’s inception in 1970 until 2011. She earned the Daytime Emmy Award for Outstanding Lead Actress for the role in 1999 after nineteen nominations – and in December 2023, received the Daytime Emmy Lifetime Achievement Award. Lucci’s body of work also includes numerous television series, films and the Broadway stage. She is the author of All my Life: A Memoir and is a National Spokesperson for the American Heart Association. Susan Lucci talks with host Alec Baldwin about how she played a role that evolved over decades, how she realized a lifelong dream of performing on Broadway, and her thoughts on the rumors of a potential reboot of the beloved soap. Originally aired January 23rd, 2024.See omnystudio.com/listener for privacy information.

A U.S. fighter jet went down in Iran and there's been a shakeup of Army leadership. The retirement of a privacy officer at the Department of Justice shines a light on the Trump Administration's interest in voter information.And, the American Heart Association releases its guidance on the pattern of eating that promotes good health and helps fend off disease.Please help us out by completing a short survey telling us what you like and how we could improve our podcast. You can find it right now at www.npr.org/springsurveyWant more analysis of the most important news of the day, plus a little fun? Subscribe to the Up First newsletter.To manage podcast ad preferences, review the links below:See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy

If you thought high cholesterol was something to worry about later in life, you're not alone. But new advice has a lot of people wondering if they should be getting checked sooner. Dr. Sanjay Gupta breaks down the new guidelines, who should pay attention, and what it actually means for you.  Want to check your risk? Try the American Heart Association's PREVENT calculator.    Producer: Kyra Dahring    Medical Writer: Andrea Kane    Showrunner: Amanda Sealy    Senior Producer: Dan Bloom    Technical Director: Dan Dzula  Learn more about your ad choices. Visit podcastchoices.com/adchoices

1. ABC cancels Taylor Frankie Paul's season of ‘The Bachelorette' in wake of horrifying abuse video (Page Six) (13:48) 2. Secret Lives of Mormon Wives Star Jessi Ngatikaura's Husband Jordan Files for Divorce (PEOPLE) (32:03) 3. Usher and Justin Bieber Have Heated Exchange At Beyoncé's Oscars After-Party (TMZ) (42:50) 4. Demi Lovato sets record straight on viral ‘Heart Attack' performance at American Heart Association event (Page Six) (47:37) 5. ‘SNL' Launches Short-Form Series ‘The Rundown'; Colin Jost Picks a Favorite Cold Open in First Episode (Variety) (51:25) - Queenie and Weenie of The Week (52:05) The Toast with Jackie (@JackieOshry) and Claudia Oshry (@girlwithnojob) ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Toast Patreon ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Toast Merch ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Girl With No Job by Claudia Oshry ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Camper & The Counselor⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Lean In Learn more about your ad choices. Visit megaphone.fm/adchoices